Canadian Drug Policy Coalition
The Canadian Drug Policy Coalition is a Vancouver-based Canadian non-profit that advocates for evidence-based drug policy through research, education, and policy engagement aimed at Canadian policymakers and the public.
- Company typePrivate
- Founded-
- HeadquartersVancouver, Canada
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Canadian Drug Policy Coalition does
The Canadian Drug Policy Coalition is a Canadian non-profit organization headquartered in Vancouver that advocates for evidence-based drug policy through research, education, and policy engagement. Its stated mission centers on shaping drug-policy outcomes in Canada via research dissemination, stakeholder education, and direct engagement with policymakers and the public. The organization operates with a small team (1-10 employees) and maintains a public-facing website at drugpolicy.ca as its primary information channel.
The organization's core activities—research, education, and policy advocacy—do not involve a commercial product line, proprietary technology platform, or revenue-generating transactions in the conventional sense. No core technology, proprietary features, products, services, or AI/ML capabilities are disclosed in the available source data. The website returned only a loading/verification page during data collection, indicating that further verification of operational details is not possible from the current input set.
As a non-profit policy coalition, the business model is presumably grant and donation funded rather than transaction-based, though no specific funders, revenue figures, pricing models, or financial details are disclosed in the source data. No partnerships, awards, certifications, leadership team, headcount details, subsidiaries, or operating geographies are documented. The available evidence supports only a minimal descriptive baseline; any deeper commercial, technical, or financial assessment would require primary-source data not present in this input.
Canadian Drug Policy Coalition firmographics
Firmographics- Name
- Canadian Drug Policy Coalition
- Website
- https://drugpolicy.ca
- Company type
- Private
- Headcount range
- 1–10 employees
- Short description
- The Canadian Drug Policy Coalition is a Vancouver-based Canadian non-profit that advocates for evidence-based drug policy through research, education, and policy engagement aimed at Canadian policymakers and the public.
- Ownership category
- akta.pro rank
Canadian Drug Policy Coalition industry classification
Industry- Product category
- Public Health Policy Advocacy
- NAICS
- Other Social Advocacy Organizations (813319), Research and Development in the Social Sciences and Humanities (54172), Human Rights Organizations (813311)
- SIC
- Services-Membership Organizations (8600), Services-Health Services (8000)
- akta.pro primary industry
- Think Tanks, Policy Research & Public Policy Institutes (BPAGAFAO)
- akta.pro secondary industries
- Gun Violence Prevention & Public Safety Policy Advocacy (BPAGAFAM), Public Health Strategy, Policy & Legislation (HLAJAMAA)
Keywords
Where Canadian Drug Policy Coalition is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Markets served
Canadian Drug Policy Coalition business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Canadian Drug Policy Coalition product offering
Product offeringCore offering
The Canadian Drug Policy Coalition is a non-profit advocacy organization that advances evidence-based drug policy in Canada. It carries out policy-oriented research, public and stakeholder education, and direct engagement with policymakers to influence drug policy outcomes. Its deliverables are research outputs, educational resources, and policy recommendations rather than commercial products or technology platforms.
Differentiator
Problem solved
Functional benefit
Products and services
- Drug Policy Research Policy-oriented research on drug policy, substance use, and harm reduction, produced for policymakers, public health authorities, and allied non-profit organizations in Canada.
- Public and Stakeholder Education on Drug Policy Educational resources and programs aimed at informing the public, policymakers, and stakeholder organizations about evidence-based approaches to drug policy and harm reduction.
- Policy Engagement and Advocacy Direct engagement with Canadian policymakers and government stakeholders to advocate for evidence-based drug policy reforms, coordinated through a coalition of partner organizations.
Companies that use Canadian Drug Policy Coalition
Customer profileIdeal customer profiles1 record
Canadian Drug Policy Coalition technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Canadian Drug Policy Coalition partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Canadian Drug Policy Coalition competitors and assessment
Company assessmentBroad incumbents
- Centre for Addiction and Mental Health (CAMH): Canada's largest mental-health and addiction teaching hospital and research center; comparable as an evidence-producing health institution shaping Canadian drug and addiction policy.
- European Monitoring Centre for Drugs and Drug Addiction (EUDA): EU agency producing authoritative evidence on drug policy and substance use; comparable as an evidence-generating body informing drug policy, though government-affiliated.
- Canadian Public Health Association: National Canadian public-health membership association; comparable as an advocacy body publishing research and policy positions, including on substance use.
Direct peers
- Drug Policy Alliance: Largest U.S.-based drug policy reform advocacy organization; comparable as a national advocacy coalition promoting evidence-based drug policy reform including decriminalization and harm reduction.
- Canadian Centre on Substance Use and Addiction (CCSA): Canadian national body providing research, evidence, and policy advice on substance use; directly comparable as a Canadian evidence-based drug policy organization.
- Harm Reduction International: International NGO advancing harm-reduction drug policy globally; comparable mission to CDPC in promoting evidence-based, rights-respecting drug policy frameworks.
- International Drug Policy Consortium (IDPC): Global network of NGOs promoting drug-policy reform; comparable as a coalition-style advocacy network producing research and policy engagement outputs.
Emerging players
- Students for Sensible Drug Policy: Youth- and student-led drug-policy reform network; comparable in mission around evidence-based policy reform, though focused on grassroots/youth mobilization.
Regional players
- Transform Drug Policy Foundation: UK-based drug policy think tank promoting evidence-based reform; comparable in function as a research-and-advocacy organization, but operating in a different geography than CDPC.
- Pivot Legal Society: Vancouver-based social-justice legal advocacy organization; comparable as a regionally focused policy advocacy NGO working on drug policy and marginalized populations.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Canadian Drug Policy Coalition social profiles
Digital presenceCanadian Drug Policy Coalition financial estimates
Financial estimateRevenue estimate
Valuation estimate
Canadian Drug Policy Coalition leadership team
Management profileNumber of profiles
Canadian Drug Policy Coalition funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Canadian Drug Policy Coalition M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Canadian Drug Policy Coalition
What does Canadian Drug Policy Coalition do?
The Canadian Drug Policy Coalition is a non-profit advocacy organization that advances evidence-based drug policy in Canada. It carries out policy-oriented research, public and stakeholder education, and direct engagement with policymakers to influence drug policy outcomes. Its deliverables are research outputs, educational resources, and policy recommendations rather than commercial products or technology platforms.
When was Canadian Drug Policy Coalition founded?
Canadian Drug Policy Coalition was founded in -1. It employs 1 to 10 people.
Where is Canadian Drug Policy Coalition based?
Canadian Drug Policy Coalition is headquartered in Vancouver, Canada, in the North America region.
Who are Canadian Drug Policy Coalition's main competitors?
Broad incumbents on record are Centre for Addiction and Mental Health (CAMH), European Monitoring Centre for Drugs and Drug Addiction (EUDA) and Canadian Public Health Association. Direct peers are Drug Policy Alliance, Canadian Centre on Substance Use and Addiction (CCSA), Harm Reduction International and International Drug Policy Consortium (IDPC). Students for Sensible Drug Policy is listed as an emerging player. Regional players are Transform Drug Policy Foundation and Pivot Legal Society.
Does Canadian Drug Policy Coalition have an API?
No public API is recorded for Canadian Drug Policy Coalition.
What industry is Canadian Drug Policy Coalition in?
Canadian Drug Policy Coalition's product category is Public Health Policy Advocacy. Its primary akta.pro industry code is BPAGAFAO, Think Tanks, Policy Research & Public Policy Institutes, with a secondary code of BPAGAFAM, Gun Violence Prevention & Public Safety Policy Advocacy. Its NAICS code is 813319 and its SIC code is 8600.